Therefore, accurate information on the distribution of MTHFR polymorphism as well as the influence of MTHFR polymorphisms on CHD patients with specific ages will be beneficial for gene–disease association studies and health impact assessment. This evidence concerns the gene MTHFR and coronary artery disorder.